Previous studies have reported that endothelial monocyte-activating protein II (EMAP-II) levels are increased in chronic inflammatory and obstructive lung disease [13,14] and that EMAP-II monoclonal antibody abrogated Influenza A Virus (IAV)-induced lung injury [15]. Here, AIMP1 is linked to Airway obstruction.